• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. EPIC STENTED TISSUE VALVE (UNKNOWN); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. EPIC STENTED TISSUE VALVE (UNKNOWN); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number E100-33M
Device Problems Biocompatibility (2886); No Apparent Adverse Event (3189)
Patient Problems Myocardial Infarction (1969); Pleural Effusion (2010); Pulmonary Edema (2020); Thrombosis/Thrombus (4440); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 11/26/2021
Event Type  Death  
Manufacturer Narrative
Further information regarding this event has been requested.The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
It was reported on an unknown date an epic stented tissue valve was implanted.Post procedure, a valve thrombosis was noted in the left and right cavities.The patient was in the intensive care unit (icu) on extracorporeal membrane oxygenation (ecmo).A hemorrhage without heparin induced thrombocytopenia was reported.Upon autopsy review, it was noted that the patient had a pleural effusion, inferior lateral white myocardial infarction, clots adhered at the tricuspid valve as well left atrium and mitral valve.Additional information has been requested and is pending.
 
Event Description
It was reported on (b)(6) 2021, a 33mm epic stented porcine heart valve w/flexfit system.Post procedure, a valve thrombosis was noted in the left and right cavities.The patient was in the intensive care unit (icu) on extracorporeal membrane oxygenation (ecmo).A hemorrhage without heparin induced thrombocytopenia was reported.On (b)(6) 2021, the patient died.Upon autopsy review, it was noted that the patient had a pleural effusion, inferior lateral white myocardial infarction, clots adhered at the tricuspid valve as well left atrium and mitral valve.
 
Manufacturer Narrative
Explant due to patient death reported.The investigation found that there were no significant pathological changes to the bioprosthetic tissue valve.There was non-adherent focal blood on the inflow surface, likely procedure-related.There was no inflammation, thrombi, or significant calcifications.The device history record was reviewed to ensure each manufacturing and inspection operation was performed, and the product met all specifications.The cause of the reported event could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC STENTED TISSUE VALVE (UNKNOWN)
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.
177 east county road b
st. paul MN 55117
Manufacturer (Section G)
ST. JUDE MEDICAL, INC.
177 east county road b
st. paul MN 55117
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key13057252
MDR Text Key282603314
Report Number3007113487-2021-00126
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberE100-33M
Device Catalogue NumberE100-33M
Device Lot NumberBR00029722
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/03/2021
Initial Date FDA Received12/21/2021
Supplement Dates Manufacturer Received12/23/2021
04/12/2022
Supplement Dates FDA Received01/04/2022
04/24/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Death;
-
-